You are currently viewing a new version of our website. To view the old version click .

p53 Signaling and Cancer

This special issue belongs to the section “Cell Signaling“.

Special Issue Information

Dear Colleagues,

About 40 years ago, p53 was initially discovered as a protein that binds to the large T antigen of the tumor virus SV40. However, since the p53 was proven to be a tumor suppressor in 1989, research on p53 has always attracted researchers from all over the world through the use of advanced technologies. However, despite more than 40 years of research, p53-regulated tumor suppression mechanisms remain a mystery, with the induction of cell death and cell cycle arrest considered to be among the most relevant regulatory aspects. In addition to cell death by apoptosis induction by p53, the mechanism of tumor suppressive effect of p53 has been broadened to include ferroptosis regulation by iron-dependent lipid peroxidation. Furthermore, recent studies are revealing that p53 exerts its tumor suppressive effects by regulating energy metabolism, antioxidant function, and metabolic reprogramming in cells. Thus, it is still necessary to elucidate the ever-expanding tumor suppressive function of p53. Here, we welcome original papers and review articles that will help us to understand the tumor suppressor role of p53 in cancer. In addition, papers on the study of p53 signaling and the development of therapies will be discussed.

Dr. Yasumichi Inoue
Prof. Dr. Hidetoshi Hayashi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • p53
  • apoptosis
  • cell cycle
  • ferroptosis
  • cancer therapy
  • signal transduction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409